nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—lung cancer	0.151	0.512	CbGaD
Mirabegron—ABCB1—lung cancer	0.144	0.488	CbGaD
Mirabegron—ORM1—Gefitinib—lung cancer	0.0731	0.141	CbGbCtD
Mirabegron—ORM1—Erlotinib—lung cancer	0.0432	0.0832	CbGbCtD
Mirabegron—BCHE—Irinotecan—lung cancer	0.0338	0.0651	CbGbCtD
Mirabegron—ALB—Gefitinib—lung cancer	0.0307	0.0592	CbGbCtD
Mirabegron—BCHE—Cisplatin—lung cancer	0.0276	0.0531	CbGbCtD
Mirabegron—ALB—Erlotinib—lung cancer	0.0182	0.035	CbGbCtD
Mirabegron—ABCB1—Topotecan—lung cancer	0.0176	0.0338	CbGbCtD
Mirabegron—SLCO1A2—Methotrexate—lung cancer	0.0168	0.0324	CbGbCtD
Mirabegron—ALB—Irinotecan—lung cancer	0.0164	0.0316	CbGbCtD
Mirabegron—ABCB1—Gefitinib—lung cancer	0.0161	0.031	CbGbCtD
Mirabegron—CYP2D6—Gefitinib—lung cancer	0.0152	0.0292	CbGbCtD
Mirabegron—ABCB1—Vinorelbine—lung cancer	0.0124	0.0238	CbGbCtD
Mirabegron—CYP2D6—Vinorelbine—lung cancer	0.0117	0.0225	CbGbCtD
Mirabegron—CYP3A4—Topotecan—lung cancer	0.0105	0.0203	CbGbCtD
Mirabegron—ABCB1—Crizotinib—lung cancer	0.00986	0.019	CbGbCtD
Mirabegron—CYP3A4—Gefitinib—lung cancer	0.00963	0.0185	CbGbCtD
Mirabegron—ABCB1—Gemcitabine—lung cancer	0.00963	0.0185	CbGbCtD
Mirabegron—ABCB1—Erlotinib—lung cancer	0.00951	0.0183	CbGbCtD
Mirabegron—CYP3A4—Teniposide—lung cancer	0.00934	0.018	CbGbCtD
Mirabegron—CYP2D6—Erlotinib—lung cancer	0.00896	0.0172	CbGbCtD
Mirabegron—ABCB1—Paclitaxel—lung cancer	0.0087	0.0168	CbGbCtD
Mirabegron—ALB—Methotrexate—lung cancer	0.00869	0.0167	CbGbCtD
Mirabegron—ABCB1—Irinotecan—lung cancer	0.00859	0.0165	CbGbCtD
Mirabegron—ABCB1—Vinblastine—lung cancer	0.00763	0.0147	CbGbCtD
Mirabegron—CYP3A4—Vinorelbine—lung cancer	0.00742	0.0143	CbGbCtD
Mirabegron—CYP2D6—Vinblastine—lung cancer	0.00719	0.0138	CbGbCtD
Mirabegron—ABCB1—Cisplatin—lung cancer	0.007	0.0135	CbGbCtD
Mirabegron—ABCB1—Etoposide—lung cancer	0.00688	0.0132	CbGbCtD
Mirabegron—ABCB1—Docetaxel—lung cancer	0.00629	0.0121	CbGbCtD
Mirabegron—CYP3A4—Crizotinib—lung cancer	0.00591	0.0114	CbGbCtD
Mirabegron—CYP3A4—Erlotinib—lung cancer	0.0057	0.011	CbGbCtD
Mirabegron—CYP3A4—Paclitaxel—lung cancer	0.00521	0.01	CbGbCtD
Mirabegron—CYP3A4—Irinotecan—lung cancer	0.00514	0.0099	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—lung cancer	0.00469	0.00903	CbGbCtD
Mirabegron—CYP3A4—Vinblastine—lung cancer	0.00457	0.0088	CbGbCtD
Mirabegron—ABCB1—Methotrexate—lung cancer	0.00454	0.00875	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—lung cancer	0.00442	0.00851	CbGbCtD
Mirabegron—CYP3A4—Etoposide—lung cancer	0.00412	0.00793	CbGbCtD
Mirabegron—CYP3A4—Docetaxel—lung cancer	0.00377	0.00726	CbGbCtD
Mirabegron—CYP3A4—Doxorubicin—lung cancer	0.00281	0.00541	CbGbCtD
Mirabegron—BCHE—diaphragm—lung cancer	0.00153	0.413	CbGeAlD
Mirabegron—ALB—mammary gland—lung cancer	0.00037	0.1	CbGeAlD
Mirabegron—Erythema multiforme—Etoposide—lung cancer	0.000185	0.00146	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000185	0.00146	CcSEcCtD
Mirabegron—Eye disorder—Etoposide—lung cancer	0.000183	0.00145	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—lung cancer	0.000183	0.00145	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—lung cancer	0.000183	0.00145	CcSEcCtD
Mirabegron—Cardiac disorder—Etoposide—lung cancer	0.000182	0.00144	CcSEcCtD
Mirabegron—Erythema multiforme—Paclitaxel—lung cancer	0.000182	0.00143	CcSEcCtD
Mirabegron—Infestation NOS—Docetaxel—lung cancer	0.000182	0.00143	CcSEcCtD
Mirabegron—Infestation—Docetaxel—lung cancer	0.000182	0.00143	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00018	0.00142	CcSEcCtD
Mirabegron—Eye disorder—Paclitaxel—lung cancer	0.00018	0.00142	CcSEcCtD
Mirabegron—Cardiac disorder—Paclitaxel—lung cancer	0.000178	0.00141	CcSEcCtD
Mirabegron—Hypertension—Irinotecan—lung cancer	0.000177	0.0014	CcSEcCtD
Mirabegron—Vision blurred—Cisplatin—lung cancer	0.000176	0.00139	CcSEcCtD
Mirabegron—Asthenia—Vinblastine—lung cancer	0.000175	0.00138	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000175	0.00138	CcSEcCtD
Mirabegron—Fatigue—Vinorelbine—lung cancer	0.000175	0.00138	CcSEcCtD
Mirabegron—BCHE—respiratory system—lung cancer	0.000174	0.0472	CbGeAlD
Mirabegron—Constipation—Vinorelbine—lung cancer	0.000174	0.00137	CcSEcCtD
Mirabegron—Cerebrovascular accident—Methotrexate—lung cancer	0.000173	0.00137	CcSEcCtD
Mirabegron—Hypertension—Gemcitabine—lung cancer	0.000173	0.00136	CcSEcCtD
Mirabegron—Asthenia—Topotecan—lung cancer	0.00017	0.00134	CcSEcCtD
Mirabegron—Arthralgia—Gemcitabine—lung cancer	0.00017	0.00134	CcSEcCtD
Mirabegron—Osteoarthritis—Methotrexate—lung cancer	0.00017	0.00134	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000169	0.00133	CcSEcCtD
Mirabegron—Asthenia—Erlotinib—lung cancer	0.000169	0.00133	CcSEcCtD
Mirabegron—Pruritus—Topotecan—lung cancer	0.000168	0.00133	CcSEcCtD
Mirabegron—Diarrhoea—Vinblastine—lung cancer	0.000167	0.00132	CcSEcCtD
Mirabegron—Infection—Irinotecan—lung cancer	0.000166	0.00131	CcSEcCtD
Mirabegron—Pruritus—Erlotinib—lung cancer	0.000166	0.00131	CcSEcCtD
Mirabegron—Gastrointestinal pain—Vinorelbine—lung cancer	0.000166	0.00131	CcSEcCtD
Mirabegron—Back pain—Etoposide—lung cancer	0.000165	0.0013	CcSEcCtD
Mirabegron—ORM1—bone marrow—lung cancer	0.000165	0.0446	CbGeAlD
Mirabegron—Vascular purpura—Doxorubicin—lung cancer	0.000164	0.0013	CcSEcCtD
Mirabegron—Rhinitis—Docetaxel—lung cancer	0.000163	0.00129	CcSEcCtD
Mirabegron—Diarrhoea—Topotecan—lung cancer	0.000162	0.00128	CcSEcCtD
Mirabegron—Infection—Gemcitabine—lung cancer	0.000162	0.00128	CcSEcCtD
Mirabegron—Back pain—Paclitaxel—lung cancer	0.000162	0.00128	CcSEcCtD
Mirabegron—Dizziness—Vinblastine—lung cancer	0.000162	0.00128	CcSEcCtD
Mirabegron—Urticaria—Vinorelbine—lung cancer	0.000161	0.00127	CcSEcCtD
Mirabegron—Urinary tract disorder—Docetaxel—lung cancer	0.000161	0.00127	CcSEcCtD
Mirabegron—Diarrhoea—Erlotinib—lung cancer	0.000161	0.00127	CcSEcCtD
Mirabegron—Abdominal pain—Vinorelbine—lung cancer	0.000161	0.00127	CcSEcCtD
Mirabegron—Connective tissue disorder—Docetaxel—lung cancer	0.00016	0.00126	CcSEcCtD
Mirabegron—Urethral disorder—Docetaxel—lung cancer	0.00016	0.00126	CcSEcCtD
Mirabegron—Skin disorder—Gemcitabine—lung cancer	0.000159	0.00125	CcSEcCtD
Mirabegron—Vision blurred—Paclitaxel—lung cancer	0.000158	0.00124	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000158	0.00124	CcSEcCtD
Mirabegron—Dizziness—Topotecan—lung cancer	0.000157	0.00124	CcSEcCtD
Mirabegron—Dizziness—Erlotinib—lung cancer	0.000155	0.00123	CcSEcCtD
Mirabegron—Erythema multiforme—Docetaxel—lung cancer	0.000154	0.00122	CcSEcCtD
Mirabegron—Breast disorder—Methotrexate—lung cancer	0.000153	0.00121	CcSEcCtD
Mirabegron—Headache—Vinblastine—lung cancer	0.000153	0.00121	CcSEcCtD
Mirabegron—Purpura—Doxorubicin—lung cancer	0.000153	0.0012	CcSEcCtD
Mirabegron—Eye disorder—Docetaxel—lung cancer	0.000152	0.0012	CcSEcCtD
Mirabegron—Cardiac disorder—Docetaxel—lung cancer	0.000151	0.00119	CcSEcCtD
Mirabegron—Infection—Cisplatin—lung cancer	0.000151	0.00119	CcSEcCtD
Mirabegron—Cerebrovascular accident—Doxorubicin—lung cancer	0.00015	0.00118	CcSEcCtD
Mirabegron—Rash—Topotecan—lung cancer	0.00015	0.00118	CcSEcCtD
Mirabegron—Dermatitis—Topotecan—lung cancer	0.00015	0.00118	CcSEcCtD
Mirabegron—ORM1—lung—lung cancer	0.000149	0.0404	CbGeAlD
Mirabegron—Headache—Topotecan—lung cancer	0.000149	0.00117	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000149	0.00117	CcSEcCtD
Mirabegron—Tachycardia—Cisplatin—lung cancer	0.000148	0.00117	CcSEcCtD
Mirabegron—Rash—Erlotinib—lung cancer	0.000148	0.00117	CcSEcCtD
Mirabegron—Dermatitis—Erlotinib—lung cancer	0.000148	0.00117	CcSEcCtD
Mirabegron—Palpitations—Paclitaxel—lung cancer	0.000148	0.00117	CcSEcCtD
Mirabegron—Skin disorder—Cisplatin—lung cancer	0.000148	0.00117	CcSEcCtD
Mirabegron—Dyspepsia—Irinotecan—lung cancer	0.000147	0.00116	CcSEcCtD
Mirabegron—Hypertension—Etoposide—lung cancer	0.000147	0.00116	CcSEcCtD
Mirabegron—Headache—Erlotinib—lung cancer	0.000147	0.00116	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—lung cancer	0.000147	0.00116	CcSEcCtD
Mirabegron—Asthenia—Vinorelbine—lung cancer	0.000146	0.00115	CcSEcCtD
Mirabegron—Nausea—Vinblastine—lung cancer	0.000145	0.00115	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Irinotecan—lung cancer	0.000145	0.00114	CcSEcCtD
Mirabegron—Hypertension—Paclitaxel—lung cancer	0.000145	0.00114	CcSEcCtD
Mirabegron—Fatigue—Irinotecan—lung cancer	0.000144	0.00114	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000144	0.00114	CcSEcCtD
Mirabegron—Pruritus—Vinorelbine—lung cancer	0.000144	0.00113	CcSEcCtD
Mirabegron—BCHE—bronchus—lung cancer	0.000143	0.0388	CbGeAlD
Mirabegron—Constipation—Irinotecan—lung cancer	0.000143	0.00113	CcSEcCtD
Mirabegron—Arthralgia—Paclitaxel—lung cancer	0.000143	0.00112	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000142	0.00112	CcSEcCtD
Mirabegron—Nausea—Topotecan—lung cancer	0.000141	0.00111	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000141	0.00111	CcSEcCtD
Mirabegron—Fatigue—Gemcitabine—lung cancer	0.000141	0.00111	CcSEcCtD
Mirabegron—Constipation—Gemcitabine—lung cancer	0.00014	0.0011	CcSEcCtD
Mirabegron—Nausea—Erlotinib—lung cancer	0.00014	0.0011	CcSEcCtD
Mirabegron—Dry mouth—Paclitaxel—lung cancer	0.000139	0.0011	CcSEcCtD
Mirabegron—Diarrhoea—Vinorelbine—lung cancer	0.000139	0.0011	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000139	0.00109	CcSEcCtD
Mirabegron—Infection—Etoposide—lung cancer	0.000138	0.00109	CcSEcCtD
Mirabegron—Back pain—Docetaxel—lung cancer	0.000137	0.00108	CcSEcCtD
Mirabegron—Gastrointestinal pain—Irinotecan—lung cancer	0.000137	0.00108	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Methotrexate—lung cancer	0.000136	0.00108	CcSEcCtD
Mirabegron—Tachycardia—Etoposide—lung cancer	0.000136	0.00107	CcSEcCtD
Mirabegron—Infection—Paclitaxel—lung cancer	0.000136	0.00107	CcSEcCtD
Mirabegron—Skin disorder—Etoposide—lung cancer	0.000135	0.00107	CcSEcCtD
Mirabegron—Dizziness—Vinorelbine—lung cancer	0.000134	0.00106	CcSEcCtD
Mirabegron—Tachycardia—Paclitaxel—lung cancer	0.000133	0.00105	CcSEcCtD
Mirabegron—Breast disorder—Doxorubicin—lung cancer	0.000133	0.00105	CcSEcCtD
Mirabegron—Skin disorder—Paclitaxel—lung cancer	0.000133	0.00105	CcSEcCtD
Mirabegron—Abdominal pain—Irinotecan—lung cancer	0.000132	0.00105	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000132	0.00104	CcSEcCtD
Mirabegron—SLCO1A2—lung—lung cancer	0.000132	0.0356	CbGeAlD
Mirabegron—Nasopharyngitis—Doxorubicin—lung cancer	0.000132	0.00104	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Cisplatin—lung cancer	0.000131	0.00104	CcSEcCtD
Mirabegron—Infestation—Methotrexate—lung cancer	0.000131	0.00103	CcSEcCtD
Mirabegron—Infestation NOS—Methotrexate—lung cancer	0.000131	0.00103	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—lung cancer	0.00013	0.00103	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00013	0.00102	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.00013	0.00102	CcSEcCtD
Mirabegron—BCHE—trachea—lung cancer	0.000129	0.0348	CbGeAlD
Mirabegron—Rash—Vinorelbine—lung cancer	0.000128	0.00101	CcSEcCtD
Mirabegron—Dermatitis—Vinorelbine—lung cancer	0.000128	0.00101	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—lung cancer	0.000128	0.00101	CcSEcCtD
Mirabegron—Headache—Vinorelbine—lung cancer	0.000127	0.001	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—lung cancer	0.000127	0.001	CcSEcCtD
Mirabegron—Palpitations—Docetaxel—lung cancer	0.000125	0.000989	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000124	0.000982	CcSEcCtD
Mirabegron—Hypertension—Docetaxel—lung cancer	0.000123	0.000967	CcSEcCtD
Mirabegron—BCHE—cardiac atrium—lung cancer	0.000121	0.0327	CbGeAlD
Mirabegron—Arthralgia—Docetaxel—lung cancer	0.000121	0.000953	CcSEcCtD
Mirabegron—Nausea—Vinorelbine—lung cancer	0.000121	0.000952	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Etoposide—lung cancer	0.00012	0.000949	CcSEcCtD
Mirabegron—Dyspepsia—Paclitaxel—lung cancer	0.00012	0.000949	CcSEcCtD
Mirabegron—Asthenia—Irinotecan—lung cancer	0.00012	0.000948	CcSEcCtD
Mirabegron—Fatigue—Etoposide—lung cancer	0.00012	0.000948	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00012	0.000947	CcSEcCtD
Mirabegron—Constipation—Etoposide—lung cancer	0.000119	0.00094	CcSEcCtD
Mirabegron—Dry mouth—Docetaxel—lung cancer	0.000118	0.000932	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000118	0.000932	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000118	0.000931	CcSEcCtD
Mirabegron—Fatigue—Paclitaxel—lung cancer	0.000118	0.00093	CcSEcCtD
Mirabegron—Asthenia—Gemcitabine—lung cancer	0.000117	0.000924	CcSEcCtD
Mirabegron—Constipation—Paclitaxel—lung cancer	0.000117	0.000922	CcSEcCtD
Mirabegron—Urinary tract disorder—Methotrexate—lung cancer	0.000116	0.000916	CcSEcCtD
Mirabegron—Pruritus—Gemcitabine—lung cancer	0.000115	0.000911	CcSEcCtD
Mirabegron—Urethral disorder—Methotrexate—lung cancer	0.000115	0.000909	CcSEcCtD
Mirabegron—Infection—Docetaxel—lung cancer	0.000115	0.000908	CcSEcCtD
Mirabegron—Diarrhoea—Irinotecan—lung cancer	0.000115	0.000904	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etoposide—lung cancer	0.000114	0.000899	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—lung cancer	0.000113	0.000894	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—lung cancer	0.000113	0.000894	CcSEcCtD
Mirabegron—Tachycardia—Docetaxel—lung cancer	0.000113	0.000892	CcSEcCtD
Mirabegron—Skin disorder—Docetaxel—lung cancer	0.000112	0.000888	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000112	0.000887	CcSEcCtD
Mirabegron—Gastrointestinal pain—Paclitaxel—lung cancer	0.000112	0.000882	CcSEcCtD
Mirabegron—Diarrhoea—Gemcitabine—lung cancer	0.000112	0.000881	CcSEcCtD
Mirabegron—Erythema multiforme—Methotrexate—lung cancer	0.000111	0.000877	CcSEcCtD
Mirabegron—Dizziness—Irinotecan—lung cancer	0.000111	0.000874	CcSEcCtD
Mirabegron—Urticaria—Etoposide—lung cancer	0.000111	0.000874	CcSEcCtD
Mirabegron—Abdominal pain—Etoposide—lung cancer	0.00011	0.000869	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—lung cancer	0.00011	0.000869	CcSEcCtD
Mirabegron—Eye disorder—Methotrexate—lung cancer	0.00011	0.000866	CcSEcCtD
Mirabegron—Asthenia—Cisplatin—lung cancer	0.000109	0.000861	CcSEcCtD
Mirabegron—Cardiac disorder—Methotrexate—lung cancer	0.000109	0.00086	CcSEcCtD
Mirabegron—Urticaria—Paclitaxel—lung cancer	0.000109	0.000856	CcSEcCtD
Mirabegron—Abdominal pain—Paclitaxel—lung cancer	0.000108	0.000852	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—lung cancer	0.000106	0.000839	CcSEcCtD
Mirabegron—Rash—Irinotecan—lung cancer	0.000106	0.000834	CcSEcCtD
Mirabegron—Dermatitis—Irinotecan—lung cancer	0.000106	0.000833	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000106	0.000833	CcSEcCtD
Mirabegron—Headache—Irinotecan—lung cancer	0.000105	0.000828	CcSEcCtD
Mirabegron—Diarrhoea—Cisplatin—lung cancer	0.000104	0.000821	CcSEcCtD
Mirabegron—Rash—Gemcitabine—lung cancer	0.000103	0.000812	CcSEcCtD
Mirabegron—Dermatitis—Gemcitabine—lung cancer	0.000103	0.000811	CcSEcCtD
Mirabegron—Headache—Gemcitabine—lung cancer	0.000102	0.000807	CcSEcCtD
Mirabegron—BCHE—bone marrow—lung cancer	0.000102	0.0276	CbGeAlD
Mirabegron—ORM1—lymph node—lung cancer	0.000102	0.0276	CbGeAlD
Mirabegron—Rhinitis—Doxorubicin—lung cancer	0.000102	0.000805	CcSEcCtD
Mirabegron—Dyspepsia—Docetaxel—lung cancer	0.000102	0.000804	CcSEcCtD
Mirabegron—Urinary tract disorder—Doxorubicin—lung cancer	0.0001	0.000793	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Docetaxel—lung cancer	0.0001	0.000789	CcSEcCtD
Mirabegron—Asthenia—Etoposide—lung cancer	0.0001	0.000789	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—lung cancer	0.0001	0.000789	CcSEcCtD
Mirabegron—Fatigue—Docetaxel—lung cancer	9.98e-05	0.000788	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—lung cancer	9.97e-05	0.000787	CcSEcCtD
Mirabegron—Nausea—Irinotecan—lung cancer	9.95e-05	0.000785	CcSEcCtD
Mirabegron—Constipation—Docetaxel—lung cancer	9.9e-05	0.000781	CcSEcCtD
Mirabegron—Back pain—Methotrexate—lung cancer	9.89e-05	0.000781	CcSEcCtD
Mirabegron—Pruritus—Etoposide—lung cancer	9.86e-05	0.000778	CcSEcCtD
Mirabegron—Asthenia—Paclitaxel—lung cancer	9.8e-05	0.000774	CcSEcCtD
Mirabegron—Nausea—Gemcitabine—lung cancer	9.69e-05	0.000765	CcSEcCtD
Mirabegron—Pruritus—Paclitaxel—lung cancer	9.67e-05	0.000763	CcSEcCtD
Mirabegron—Vision blurred—Methotrexate—lung cancer	9.64e-05	0.000761	CcSEcCtD
Mirabegron—Erythema multiforme—Doxorubicin—lung cancer	9.62e-05	0.000759	CcSEcCtD
Mirabegron—Rash—Cisplatin—lung cancer	9.59e-05	0.000757	CcSEcCtD
Mirabegron—Dermatitis—Cisplatin—lung cancer	9.58e-05	0.000756	CcSEcCtD
Mirabegron—Diarrhoea—Etoposide—lung cancer	9.53e-05	0.000752	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—lung cancer	9.51e-05	0.00075	CcSEcCtD
Mirabegron—Gastrointestinal pain—Docetaxel—lung cancer	9.47e-05	0.000747	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—lung cancer	9.44e-05	0.000745	CcSEcCtD
Mirabegron—Diarrhoea—Paclitaxel—lung cancer	9.35e-05	0.000738	CcSEcCtD
Mirabegron—BCHE—lung—lung cancer	9.25e-05	0.025	CbGeAlD
Mirabegron—Dizziness—Etoposide—lung cancer	9.22e-05	0.000727	CcSEcCtD
Mirabegron—Abdominal pain—Docetaxel—lung cancer	9.16e-05	0.000722	CcSEcCtD
Mirabegron—Dizziness—Paclitaxel—lung cancer	9.04e-05	0.000713	CcSEcCtD
Mirabegron—Nausea—Cisplatin—lung cancer	9.04e-05	0.000713	CcSEcCtD
Mirabegron—ALB—lymph node—lung cancer	8.95e-05	0.0242	CbGeAlD
Mirabegron—Rash—Etoposide—lung cancer	8.79e-05	0.000693	CcSEcCtD
Mirabegron—Dermatitis—Etoposide—lung cancer	8.78e-05	0.000693	CcSEcCtD
Mirabegron—Headache—Etoposide—lung cancer	8.73e-05	0.000689	CcSEcCtD
Mirabegron—Arthralgia—Methotrexate—lung cancer	8.71e-05	0.000687	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.65e-05	0.000682	CcSEcCtD
Mirabegron—Rash—Paclitaxel—lung cancer	8.62e-05	0.00068	CcSEcCtD
Mirabegron—Dermatitis—Paclitaxel—lung cancer	8.61e-05	0.000679	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—lung cancer	8.57e-05	0.000676	CcSEcCtD
Mirabegron—Headache—Paclitaxel—lung cancer	8.56e-05	0.000675	CcSEcCtD
Mirabegron—Vision blurred—Doxorubicin—lung cancer	8.35e-05	0.000659	CcSEcCtD
Mirabegron—Asthenia—Docetaxel—lung cancer	8.31e-05	0.000656	CcSEcCtD
Mirabegron—ABCB1—respiratory system—lung cancer	8.3e-05	0.0225	CbGeAlD
Mirabegron—Infection—Methotrexate—lung cancer	8.29e-05	0.000654	CcSEcCtD
Mirabegron—Nausea—Etoposide—lung cancer	8.28e-05	0.000653	CcSEcCtD
Mirabegron—Pruritus—Docetaxel—lung cancer	8.19e-05	0.000647	CcSEcCtD
Mirabegron—Nausea—Paclitaxel—lung cancer	8.12e-05	0.00064	CcSEcCtD
Mirabegron—Skin disorder—Methotrexate—lung cancer	8.11e-05	0.00064	CcSEcCtD
Mirabegron—Diarrhoea—Docetaxel—lung cancer	7.92e-05	0.000625	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—lung cancer	7.83e-05	0.000618	CcSEcCtD
Mirabegron—Dizziness—Docetaxel—lung cancer	7.66e-05	0.000604	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—lung cancer	7.65e-05	0.000603	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methotrexate—lung cancer	7.6e-05	0.0006	CcSEcCtD
Mirabegron—Arthralgia—Doxorubicin—lung cancer	7.54e-05	0.000595	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.49e-05	0.000591	CcSEcCtD
Mirabegron—Dry mouth—Doxorubicin—lung cancer	7.37e-05	0.000582	CcSEcCtD
Mirabegron—Dyspepsia—Methotrexate—lung cancer	7.35e-05	0.00058	CcSEcCtD
Mirabegron—Rash—Docetaxel—lung cancer	7.3e-05	0.000576	CcSEcCtD
Mirabegron—Dermatitis—Docetaxel—lung cancer	7.3e-05	0.000576	CcSEcCtD
Mirabegron—Headache—Docetaxel—lung cancer	7.26e-05	0.000572	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Methotrexate—lung cancer	7.21e-05	0.000569	CcSEcCtD
Mirabegron—Fatigue—Methotrexate—lung cancer	7.2e-05	0.000568	CcSEcCtD
Mirabegron—Infection—Doxorubicin—lung cancer	7.18e-05	0.000567	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—lung cancer	7.05e-05	0.000557	CcSEcCtD
Mirabegron—Skin disorder—Doxorubicin—lung cancer	7.02e-05	0.000554	CcSEcCtD
Mirabegron—ABCB1—epithelium—lung cancer	6.94e-05	0.0188	CbGeAlD
Mirabegron—Nausea—Docetaxel—lung cancer	6.88e-05	0.000543	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methotrexate—lung cancer	6.83e-05	0.000539	CcSEcCtD
Mirabegron—Urticaria—Methotrexate—lung cancer	6.63e-05	0.000523	CcSEcCtD
Mirabegron—Abdominal pain—Methotrexate—lung cancer	6.6e-05	0.000521	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.59e-05	0.00052	CcSEcCtD
Mirabegron—Dyspepsia—Doxorubicin—lung cancer	6.36e-05	0.000502	CcSEcCtD
Mirabegron—BCHE—lymph node—lung cancer	6.33e-05	0.0171	CbGeAlD
Mirabegron—Gastrointestinal disorder—Doxorubicin—lung cancer	6.24e-05	0.000492	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—lung cancer	6.23e-05	0.000492	CcSEcCtD
Mirabegron—Constipation—Doxorubicin—lung cancer	6.18e-05	0.000488	CcSEcCtD
Mirabegron—ABCB1—trachea—lung cancer	6.14e-05	0.0166	CbGeAlD
Mirabegron—Asthenia—Methotrexate—lung cancer	5.99e-05	0.000473	CcSEcCtD
Mirabegron—Gastrointestinal pain—Doxorubicin—lung cancer	5.91e-05	0.000466	CcSEcCtD
Mirabegron—Pruritus—Methotrexate—lung cancer	5.91e-05	0.000466	CcSEcCtD
Mirabegron—Urticaria—Doxorubicin—lung cancer	5.74e-05	0.000453	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—lung cancer	5.71e-05	0.000451	CcSEcCtD
Mirabegron—Diarrhoea—Methotrexate—lung cancer	5.71e-05	0.000451	CcSEcCtD
Mirabegron—Dizziness—Methotrexate—lung cancer	5.52e-05	0.000436	CcSEcCtD
Mirabegron—Rash—Methotrexate—lung cancer	5.26e-05	0.000415	CcSEcCtD
Mirabegron—Dermatitis—Methotrexate—lung cancer	5.26e-05	0.000415	CcSEcCtD
Mirabegron—Headache—Methotrexate—lung cancer	5.23e-05	0.000413	CcSEcCtD
Mirabegron—Asthenia—Doxorubicin—lung cancer	5.19e-05	0.000409	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—lung cancer	5.11e-05	0.000403	CcSEcCtD
Mirabegron—Nausea—Methotrexate—lung cancer	4.96e-05	0.000391	CcSEcCtD
Mirabegron—Diarrhoea—Doxorubicin—lung cancer	4.95e-05	0.00039	CcSEcCtD
Mirabegron—ABCB1—bone marrow—lung cancer	4.87e-05	0.0132	CbGeAlD
Mirabegron—Dizziness—Doxorubicin—lung cancer	4.78e-05	0.000377	CcSEcCtD
Mirabegron—Rash—Doxorubicin—lung cancer	4.56e-05	0.00036	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—lung cancer	4.55e-05	0.000359	CcSEcCtD
Mirabegron—Headache—Doxorubicin—lung cancer	4.53e-05	0.000357	CcSEcCtD
Mirabegron—ABCB1—lung—lung cancer	4.41e-05	0.0119	CbGeAlD
Mirabegron—Nausea—Doxorubicin—lung cancer	4.29e-05	0.000339	CcSEcCtD
Mirabegron—ABCB1—lymph node—lung cancer	3.02e-05	0.00816	CbGeAlD
Mirabegron—CYP2D6—Metabolism—ABCC3—lung cancer	9.76e-06	0.000179	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—UGT1A1—lung cancer	9.74e-06	0.000178	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.74e-06	0.000178	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOA1—lung cancer	9.72e-06	0.000178	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	9.69e-06	0.000177	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—BRAF—lung cancer	9.68e-06	0.000177	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADCY1—lung cancer	9.64e-06	0.000176	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCG2—lung cancer	9.64e-06	0.000176	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6R—lung cancer	9.56e-06	0.000175	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CREBBP—lung cancer	9.54e-06	0.000175	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.54e-06	0.000175	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKR1C1—lung cancer	9.45e-06	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HPGDS—lung cancer	9.45e-06	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ENO2—lung cancer	9.45e-06	0.000173	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CD—lung cancer	9.4e-06	0.000172	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPP2R1B—lung cancer	9.39e-06	0.000172	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GNG11—lung cancer	9.39e-06	0.000172	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EGFR—lung cancer	9.38e-06	0.000172	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM2—lung cancer	9.31e-06	0.00017	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CNDP2—lung cancer	9.31e-06	0.00017	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.31e-06	0.00017	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.27e-06	0.00017	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.23e-06	0.000169	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—UGT1A1—lung cancer	9.18e-06	0.000168	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTT1—lung cancer	9.17e-06	0.000168	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAP2K1—lung cancer	9.11e-06	0.000167	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2A6—lung cancer	9.06e-06	0.000166	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GCLC—lung cancer	9.06e-06	0.000166	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTMR3—lung cancer	9.06e-06	0.000166	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CD—lung cancer	9.05e-06	0.000166	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.03e-06	0.000165	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—lung cancer	8.96e-06	0.000164	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDOA—lung cancer	8.94e-06	0.000164	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	8.88e-06	0.000163	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CG—lung cancer	8.87e-06	0.000162	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—KRAS—lung cancer	8.86e-06	0.000162	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GNG11—lung cancer	8.85e-06	0.000162	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PGAM1—lung cancer	8.83e-06	0.000162	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NCOA3—lung cancer	8.68e-06	0.000159	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ENO1—lung cancer	8.59e-06	0.000157	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	8.58e-06	0.000157	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.56e-06	0.000157	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOA1—lung cancer	8.53e-06	0.000156	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—POMC—lung cancer	8.45e-06	0.000155	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADCY1—lung cancer	8.44e-06	0.000155	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ABCG2—lung cancer	8.44e-06	0.000155	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDOA—lung cancer	8.43e-06	0.000154	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2A7—lung cancer	8.42e-06	0.000154	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—RAF1—lung cancer	8.39e-06	0.000154	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HPGDS—lung cancer	8.28e-06	0.000152	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ENO2—lung cancer	8.28e-06	0.000152	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SDC4—lung cancer	8.24e-06	0.000151	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPP2R1B—lung cancer	8.23e-06	0.000151	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CREBBP—lung cancer	8.23e-06	0.000151	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CB—lung cancer	8.19e-06	0.00015	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NCOA3—lung cancer	8.18e-06	0.00015	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.17e-06	0.00015	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—lung cancer	8.14e-06	0.000149	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MDM2—lung cancer	8.11e-06	0.000148	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RAF1—lung cancer	8.08e-06	0.000148	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTT1—lung cancer	8.03e-06	0.000147	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ERBB2—lung cancer	7.99e-06	0.000146	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCG2—lung cancer	7.96e-06	0.000146	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADCY1—lung cancer	7.96e-06	0.000146	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GCLC—lung cancer	7.94e-06	0.000145	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2A6—lung cancer	7.94e-06	0.000145	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	7.92e-06	0.000145	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MTOR—lung cancer	7.89e-06	0.000144	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CB—lung cancer	7.89e-06	0.000144	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HPGDS—lung cancer	7.8e-06	0.000143	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ENO2—lung cancer	7.8e-06	0.000143	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CD—lung cancer	7.8e-06	0.000143	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	7.79e-06	0.000143	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CG—lung cancer	7.79e-06	0.000143	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.75e-06	0.000142	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2E1—lung cancer	7.7e-06	0.000141	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—lung cancer	7.7e-06	0.000141	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NQO1—lung cancer	7.62e-06	0.000139	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—lung cancer	7.58e-06	0.000139	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTT1—lung cancer	7.57e-06	0.000139	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HRAS—lung cancer	7.53e-06	0.000138	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ENO1—lung cancer	7.53e-06	0.000138	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IL2—lung cancer	7.52e-06	0.000138	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.52e-06	0.000138	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—RRM1—lung cancer	7.51e-06	0.000137	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA3—lung cancer	7.51e-06	0.000137	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2A6—lung cancer	7.48e-06	0.000137	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GCLC—lung cancer	7.48e-06	0.000137	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.46e-06	0.000137	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—POMC—lung cancer	7.41e-06	0.000136	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.39e-06	0.000135	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—lung cancer	7.32e-06	0.000134	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.26e-06	0.000133	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—lung cancer	7.26e-06	0.000133	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL2—lung cancer	7.24e-06	0.000133	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CREBBP—lung cancer	7.22e-06	0.000132	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—lung cancer	7.21e-06	0.000132	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ENO1—lung cancer	7.09e-06	0.00013	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCND1—lung cancer	7.06e-06	0.000129	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—B4GALT5—lung cancer	7.06e-06	0.000129	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—JUN—lung cancer	7.05e-06	0.000129	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.04e-06	0.000129	CbGpPWpGaD
Mirabegron—ALB—Metabolism—STK11—lung cancer	6.87e-06	0.000126	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA4—lung cancer	6.86e-06	0.000126	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—lung cancer	6.86e-06	0.000126	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CD—lung cancer	6.84e-06	0.000125	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1A—lung cancer	6.83e-06	0.000125	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTEN—lung cancer	6.82e-06	0.000125	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CB—lung cancer	6.8e-06	0.000124	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—lung cancer	6.76e-06	0.000124	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—EP300—lung cancer	6.75e-06	0.000124	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2E1—lung cancer	6.75e-06	0.000124	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—lung cancer	6.74e-06	0.000123	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA2—lung cancer	6.69e-06	0.000122	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NQO1—lung cancer	6.67e-06	0.000122	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—lung cancer	6.65e-06	0.000122	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SRC—lung cancer	6.57e-06	0.00012	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EP300—lung cancer	6.5e-06	0.000119	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA1—lung cancer	6.45e-06	0.000118	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.45e-06	0.000118	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—lung cancer	6.4e-06	0.000117	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCC3—lung cancer	6.38e-06	0.000117	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.37e-06	0.000117	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2E1—lung cancer	6.36e-06	0.000116	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTP1—lung cancer	6.35e-06	0.000116	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SRC—lung cancer	6.32e-06	0.000116	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NRAS—lung cancer	6.32e-06	0.000116	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NQO1—lung cancer	6.29e-06	0.000115	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAT—lung cancer	6.18e-06	0.000113	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKR1C1—lung cancer	6.18e-06	0.000113	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—lung cancer	6.16e-06	0.000113	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.15e-06	0.000113	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—lung cancer	6.1e-06	0.000112	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NRAS—lung cancer	6.08e-06	0.000111	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK3—lung cancer	6.05e-06	0.000111	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—STK11—lung cancer	6.02e-06	0.00011	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCB1—lung cancer	6.01e-06	0.00011	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—UGT1A1—lung cancer	6e-06	0.00011	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CB—lung cancer	5.97e-06	0.000109	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—lung cancer	5.91e-06	0.000108	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TYMS—lung cancer	5.91e-06	0.000108	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTEN—lung cancer	5.88e-06	0.000108	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—lung cancer	5.84e-06	0.000107	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK3—lung cancer	5.82e-06	0.000107	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GNG11—lung cancer	5.79e-06	0.000106	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—STK11—lung cancer	5.67e-06	0.000104	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—lung cancer	5.66e-06	0.000104	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—EP300—lung cancer	5.6e-06	0.000103	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTP1—lung cancer	5.57e-06	0.000102	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGFR—lung cancer	5.54e-06	0.000101	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP1A1—lung cancer	5.54e-06	0.000101	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDOA—lung cancer	5.51e-06	0.000101	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ERCC2—lung cancer	5.49e-06	0.000101	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—KRAS—lung cancer	5.44e-06	9.95e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAT—lung cancer	5.42e-06	9.92e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NCOA3—lung cancer	5.35e-06	9.79e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTP1—lung cancer	5.25e-06	9.61e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KRAS—lung cancer	5.23e-06	9.58e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCG2—lung cancer	5.2e-06	9.53e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADCY1—lung cancer	5.2e-06	9.53e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TYMS—lung cancer	5.18e-06	9.48e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTEN—lung cancer	5.15e-06	9.44e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—lung cancer	5.12e-06	9.37e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAT—lung cancer	5.1e-06	9.35e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HPGDS—lung cancer	5.1e-06	9.34e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ENO2—lung cancer	5.1e-06	9.34e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.07e-06	9.28e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—lung cancer	4.99e-06	9.15e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCB1—lung cancer	4.97e-06	9.09e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTT1—lung cancer	4.95e-06	9.06e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—EP300—lung cancer	4.92e-06	9e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCLC—lung cancer	4.89e-06	8.96e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2A6—lung cancer	4.89e-06	8.96e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TYMS—lung cancer	4.88e-06	8.93e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP1A1—lung cancer	4.85e-06	8.88e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—lung cancer	4.83e-06	8.85e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—lung cancer	4.82e-06	8.83e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ERCC2—lung cancer	4.81e-06	8.81e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—lung cancer	4.81e-06	8.8e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOA1—lung cancer	4.75e-06	8.7e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—lung cancer	4.65e-06	8.52e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ENO1—lung cancer	4.64e-06	8.49e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—HRAS—lung cancer	4.62e-06	8.46e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP1A1—lung cancer	4.57e-06	8.37e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.55e-06	8.33e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ERCC2—lung cancer	4.53e-06	8.3e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HRAS—lung cancer	4.45e-06	8.15e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CG—lung cancer	4.34e-06	7.94e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—lung cancer	4.26e-06	7.8e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA1—lung cancer	4.16e-06	7.62e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2E1—lung cancer	4.16e-06	7.62e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—lung cancer	4.14e-06	7.59e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—POMC—lung cancer	4.13e-06	7.56e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NQO1—lung cancer	4.11e-06	7.53e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—lung cancer	4.08e-06	7.47e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CREBBP—lung cancer	4.02e-06	7.36e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—lung cancer	3.93e-06	7.19e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA1—lung cancer	3.92e-06	7.18e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CD—lung cancer	3.81e-06	6.98e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CG—lung cancer	3.8e-06	6.96e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—STK11—lung cancer	3.71e-06	6.79e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—lung cancer	3.64e-06	6.66e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—POMC—lung cancer	3.62e-06	6.62e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CG—lung cancer	3.58e-06	6.55e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CREBBP—lung cancer	3.52e-06	6.45e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTP1—lung cancer	3.43e-06	6.28e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—POMC—lung cancer	3.41e-06	6.24e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—lung cancer	3.39e-06	6.2e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CD—lung cancer	3.34e-06	6.11e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAT—lung cancer	3.34e-06	6.11e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CB—lung cancer	3.32e-06	6.08e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CREBBP—lung cancer	3.32e-06	6.08e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—lung cancer	3.3e-06	6.04e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—lung cancer	3.29e-06	6.03e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCB1—lung cancer	3.25e-06	5.94e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TYMS—lung cancer	3.19e-06	5.84e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—lung cancer	3.15e-06	5.77e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CD—lung cancer	3.15e-06	5.76e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—lung cancer	3.11e-06	5.69e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP1A1—lung cancer	2.99e-06	5.47e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—lung cancer	2.97e-06	5.44e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ERCC2—lung cancer	2.96e-06	5.43e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CB—lung cancer	2.91e-06	5.33e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—lung cancer	2.88e-06	5.28e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTEN—lung cancer	2.87e-06	5.26e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CB—lung cancer	2.74e-06	5.02e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—EP300—lung cancer	2.74e-06	5.01e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—lung cancer	2.72e-06	4.98e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA1—lung cancer	2.56e-06	4.69e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTEN—lung cancer	2.52e-06	4.61e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—EP300—lung cancer	2.4e-06	4.39e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTEN—lung cancer	2.37e-06	4.34e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CG—lung cancer	2.34e-06	4.29e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—EP300—lung cancer	2.26e-06	4.14e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—POMC—lung cancer	2.23e-06	4.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CREBBP—lung cancer	2.17e-06	3.97e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CD—lung cancer	2.06e-06	3.77e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—lung cancer	2.03e-06	3.72e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—lung cancer	2.03e-06	3.71e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CB—lung cancer	1.79e-06	3.28e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—lung cancer	1.78e-06	3.25e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—lung cancer	1.77e-06	3.25e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—lung cancer	1.67e-06	3.06e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—lung cancer	1.65e-06	3.03e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTEN—lung cancer	1.55e-06	2.84e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—EP300—lung cancer	1.48e-06	2.71e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—lung cancer	1.45e-06	2.65e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—lung cancer	1.37e-06	2.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—lung cancer	1.09e-06	2e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—lung cancer	8.93e-07	1.64e-05	CbGpPWpGaD
